Moreover, our published study indicated that SPR could promote hepatocellular carcinoma progression via FoxO3a/Bim signalling in a non‐enzymatic manner, while its enzymatic activity might have no effect on hepatocellular carcinoma development.44 The gene discussed is BCL2L11; the disease is hepatocellular carcinoma.